T46.6X4
Poisoning by antihyperlipidemic and antiarteriosclerotic drugs, undetermined
Clinical Classification Guidelines
Medical Intelligence & Overview
Poisoning by antihyperlipidemic and antiarteriosclerotic drugs, classified under ICD-10 code T46.6X4, refers to adverse health effects resulting from the improper or excessive use of medications designed to manage cholesterol and arterial health. These medications are often prescribed to reduce the risk of cardiovascular disease and manage lipid levels. However, when misused, it can lead to dangerous health complications requiring prompt medical attention.
Causes & Symptoms
Clinical Causes: Accidental overdose of antihyperlipidemic or antiarteriosclerotic medications Intentional overdose or misuse, possibly in suicide attempts Incorrect dosage administration due to misunderstanding of prescription instructions Drug interactions increasing toxicity risk Use of counterfeit or contaminated medications Failure to follow prescribed monitoring protocols
Key Symptoms: Nausea and vomiting Abdominal pain or discomfort Muscle weakness or pain, potentially indicating myopathy or rhabdomyolysis Liver function abnormalities, such as jaundice or elevated liver enzymes Fatigue and general malaise Confusion or altered mental state Symptoms of liver or kidney impairment Potential development of arrhythmias or cardiovascular instability
Diagnostic & Treatment
Diagnosis Path: Diagnosis involves a comprehensive medical evaluation, including detailed patient history, physical examination, and laboratory tests. Specific assessments may include:
Treatment Protocols: Treatment strategies for poisoning by antihyperlipidemic and antiarteriosclerotic drugs focus on stabilizing the patient and removing or neutralizing the toxin. Common approaches include:
Clinical Advice & FAQs
Billing Guidance
Is T46.6X4 a billable ICD-10 code?
Yes, T46.6X4 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report T46.6X4?
Clinical documentation must specify the nature of Poisoning by antihyperlipidemic and antiarteriosclerotic drugs, undetermined and any associated comorbidities for accurate reporting.
Cite this Clinical Reference